Atlas FDA

RADIESSE Injectable Implant

FDA premarket approval P050037/S080 · decided 2017-06-27

Approval details

PMA number
P050037
Supplement
S080
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
RADIESSE Injectable Implant
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2017-06-01
Decision date
2017-06-27
Days to decision
26 days
Decision code
OK30
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Installation of an alternate X-Ray Diffraction unit at Merz North America Quality Lab.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29